About 11.2 Capital
Early-phase investor in deep-tech—AI, digital security, quantum, robotics, space tech, synthetic biology—with rare bioengineering focus and technically deep partners who engage with complex product and R&D. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.

